KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Depreciation & Amortization (CF): 2009-2025

Historic Depreciation & Amortization (CF) for Acadia Pharmaceuticals (ACAD) over the last 15 years, with Sep 2025 value amounting to $227,000.

  • Acadia Pharmaceuticals' Depreciation & Amortization (CF) rose 0.44% to $227,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $895,000, marking a year-over-year decrease of 11.12%. This contributed to the annual value of $920,000 for FY2024, which is 38.67% down from last year.
  • As of Q3 2025, Acadia Pharmaceuticals' Depreciation & Amortization (CF) stood at $227,000, which was up 6.57% from $213,000 recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Depreciation & Amortization (CF) registered a high of $616,000 during Q3 2021, and its lowest value of $213,000 during Q2 2025.
  • In the last 3 years, Acadia Pharmaceuticals' Depreciation & Amortization (CF) had a median value of $229,000 in 2025 and averaged $280,818.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Depreciation & Amortization (CF) surged by 82.25% in 2021 and then slumped by 43.78% in 2024.
  • Acadia Pharmaceuticals' Depreciation & Amortization (CF) (Quarterly) stood at $535,000 in 2021, then decreased by 8.60% to $489,000 in 2022, then tumbled by 35.99% to $313,000 in 2023, then dropped by 27.80% to $226,000 in 2024, then grew by 0.44% to $227,000 in 2025.
  • Its Depreciation & Amortization (CF) was $227,000 in Q3 2025, compared to $213,000 in Q2 2025 and $229,000 in Q1 2025.